493 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
GSK GlaxoSmithKline PLC $39.21 $97.25B Sell
Article Searches
Roche's (RHHBY) sNDA for Flu Candidate Accepted by the FDA http://www.zacks.com/stock/news/357971/roches-rhhby-snda-for-flu-candidate-accepted-by-the-fda?cid=CS-ZC-FT-357971 Mar 06, 2019 - The FDA accepts Roche's (RHHBY) sNDA for Xofluza to treat influenza in people at high risk of complications.
Merck Gets CHMP Nod for Six-Week Dosing Option of Keytruda http://www.zacks.com/stock/news/357700/merck-gets-chmp-nod-for-six-week-dosing-option-of-keytruda?cid=CS-ZC-FT-357700 Mar 05, 2019 - Merck (MRK) gets CHMP recommendation for a six-week dosing schedule of Keytruda across all current monotherapy indications.
The 3 Oldest Members of Biotech's Billion-Burned Club https://www.fool.com/investing/2019/03/03/the-3-oldest-members-of-biotechs-billion-burned-cl.aspx?source=iedfolrf0000001 Mar 03, 2019 - These biopharmaceutical startups have been losing their investors' money for decades.
Mallinckrodt (MNK) Rallies as Earnings Beat Estimates in Q4 http://www.zacks.com/stock/news/357189/mallinckrodt-mnk-rallies-as-earnings-beat-estimates-in-q4?cid=CS-ZC-FT-357189 Feb 27, 2019 - Mallinckrodt (MNK) tops earnings and sales estimates in the fourth quarter leading to a gain in share price.
Theravance (TBPH) Q4 Loss Narrows, Revenues Beat Estimates http://www.zacks.com/stock/news/357180/theravance-tbph-q4-loss-narrows-revenues-beat-estimates?cid=CS-ZC-FT-357180 Feb 27, 2019 - Theravance Biopharma (TBPH) incurs narrower-than-expected loss in Q4. The top line surpasses estimates.
Bayer (BAYRY) Q4 Earnings Beat Estimates, Revenues Up Y/Y http://www.zacks.com/stock/news/357173/bayer-bayry-q4-earnings-beat-estimates-revenues-up-y-y?cid=CS-ZC-FT-357173 Feb 27, 2019 - Bayer's (BAYRY) fourth-quarter 2018 core earnings per share of 31 cents, per American Depositary Receipt ("ADR"), beat the Zacks Consensus Estimate of 26 cents.
Top Ranked Income Stocks to Buy for February 27th http://www.zacks.com/commentary/216784/top-ranked-income-stocks-to-buy-for-february-27th?cid=CS-ZC-FT-216784 Feb 27, 2019 - Top Ranked Income Stocks to Buy for February 27th
Top Ranked Income Stocks to Buy for February 26th http://www.zacks.com/commentary/216515/top-ranked-income-stocks-to-buy-for-february-26th?cid=CS-ZC-FT-216515 Feb 26, 2019 - Top Ranked Income Stocks to Buy for February 26th
The Zacks Analyst Blog Highlights: Boeing, GlaxoSmithKline and Rio Tinto http://www.zacks.com/stock/news/356964/the-zacks-analyst-blog-highlights-boeing-glaxosmithkline-and-rio-tinto?cid=CS-ZC-FT-356964 Feb 26, 2019 - The Zacks Analyst Blog Highlights: Boeing, GlaxoSmithKline and Rio Tinto
Top Ranked Income Stocks to Buy for February 22nd http://www.zacks.com/commentary/215702/top-ranked-income-stocks-to-buy-for-february-22nd?cid=CS-ZC-FT-215702 Feb 22, 2019 - Top Ranked Income Stocks to Buy for February 22nd

Pages: 12345678...50

<<<Page 3>